Swedish Orphan Biovitrum AB (publ) (BIOVF) Financial Statements
$49.03OTC: BIOVFMarket Cap $16.96B
Swedish Orphan Biovitrum AB (publ) most recently reported annual revenue of $28.2B, net profit of $477.0M, revenue has compounded at 13.0% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.